TG Therapeutics, Inc. (LON:0VGI)
London · Delayed Price · Currency is GBP · Price in USD 30.39
-6.72 (-18.11%)
Jan 9, 2026, 3:11 PM GMT
TG Therapeutics Market Cap
TG Therapeutics has a market cap or net worth of 3.09 billion as of February 12, 2026. Its market cap has decreased by -15.85% in one year.
Market Cap
3.09B
Enterprise Value
3.18B
Revenue
395.70M
Ranking
n/a
PE Ratio
9.28
Stock Price
30.39
Market Cap Chart
Since January 10, 2012, TG Therapeutics's market cap has increased from 6.62M to 3.09B, an increase of 46,568.87%. That is a compound annual growth rate of 54.65%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 10, 2026 | 3.12B | -3.75% |
| Dec 31, 2025 | 3.24B | -6.16% |
| Dec 31, 2024 | 3.45B | 81.92% |
| Dec 29, 2023 | 1.90B | 44.26% |
| Dec 30, 2022 | 1.31B | -28.44% |
| Dec 31, 2021 | 1.84B | -62.57% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 231.18B |
| GSK plc | 86.28B |
| Haleon | 36.19B |
| Smith & Nephew | 11.10B |
| Convatec Group | 4.29B |
| Hikma Pharmaceuticals | 3.48B |
| Genus | 2.04B |
| HUTCHMED (China) | 1.88B |